Electrophoresis testing - FY25 delivery order
Ended Awarded Last action
- Contract number
- W81K0023F0211
- Awardee
-
Sebia, Inc. UEI WKVRJJ6G6VB5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $192,317
Award facts
- Opportunity
-
- Sources Sought Notice - Electrophoresis Testing Platform & Reagents Pre-Solicitation · W81K0023R0021 · Posted Nov 18, 2022
- Contract value 100% obligated
- $192,317.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$204,521 | |
| Funding Only Action | -$50,000 | |
| Funding Only Action | $446,839 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $192,317.19 firm fixed-price delivery order to Sebia, Inc. for electrophoresis testing services with a performance location at Fort Sam Houston, Texas. This delivery order, issued on October 1, 2023, with an ultimate completion date of September 30, 2024, was awarded without a set-aside designation, reflecting Sebia's competitive standing in the federal marketplace. The award likely stems from Sebia's existing Blanket Purchase Agreement with the Defense Health Agency, valued at $1,649,017.58 and valid through April 2026, which provides the contractual vehicle for this delivery order.
Sebia, Inc., headquartered in Norcross, Georgia, is a specialized provider of automated electrophoresis technologies and clinical testing services with extensive experience supporting federal healthcare agencies including the Department of Defense and Department of Veterans Affairs. The company delivers comprehensive laboratory diagnostic solutions encompassing instruments, reagents, consumables, and maintenance support for electrophoresis-based testing, including serum protein electrophoresis, hemoglobin electrophoresis, immunofixation, and related clinical analyses. This delivery order represents continued fulfillment of Sebia's role as a critical supplier of laboratory diagnostic capabilities to the military medical system.
Quick answers
Who was awarded contract W81K0023F0211?
W81K0023F0211 was awarded to Sebia, Inc. by Medical Command (Department of the Army) on October 1, 2023.
How much is contract W81K0023F0211 worth?
The government has obligated $192,317 on W81K0023F0211.
Which agency awarded contract W81K0023F0211?
Medical Command (Department of the Army) awarded W81K0023F0211, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0023F0211 an order under another contract?
Yes. W81K0023F0211 is a delivery order under W81K0023D0007, an indefinite delivery contract.
Was contract W81K0023F0211 competed?
The extent of competition for W81K0023F0211 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award